Gérard Greig

614 total citations
20 papers, 483 citations indexed

About

Gérard Greig is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. According to data from OpenAlex, Gérard Greig has authored 20 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Nutrition and Dietetics. Recurrent topics in Gérard Greig's work include Clinical Nutrition and Gastroenterology (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Gérard Greig is often cited by papers focused on Clinical Nutrition and Gastroenterology (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Gérard Greig collaborates with scholars based in Switzerland, United States and France. Gérard Greig's co-authors include Amita Patnaik, Razelle Kurzrock, Sabine Eckhardt, Joseph Eid, Stephen Leong, Terri Warren, Joseph Aisner, Robert S. Benjamin, Lia Gore and Kai Habben and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Gérard Greig

19 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gérard Greig Switzerland	8	157	113	76	66	65	20	483
Richard Petrillo United States	8	337 2.1×	83 0.7×	45 0.6×	87 1.3×	50 0.8×	16	606
Sarah A. Aroner United States	15	78 0.5×	147 1.3×	23 0.3×	86 1.3×	106 1.6×	28	516
Laura Marruecos Spain	14	195 1.2×	44 0.4×	68 0.9×	77 1.2×	12 0.2×	25	561
Yu Meng China	13	155 1.0×	86 0.8×	77 1.0×	70 1.1×	26 0.4×	40	543
Jingzhi Guan China	13	102 0.6×	41 0.4×	28 0.4×	87 1.3×	18 0.3×	33	382
Pedram Daraei United States	8	138 0.9×	44 0.4×	36 0.5×	62 0.9×	15 0.2×	12	444
Andreas Moraitis United States	14	143 0.9×	309 2.7×	30 0.4×	52 0.8×	16 0.2×	41	565
S Baba Japan	12	210 1.3×	17 0.2×	69 0.9×	53 0.8×	68 1.0×	21	565
Valērija Groma Latvia	12	76 0.5×	36 0.3×	25 0.3×	50 0.8×	30 0.5×	53	385

Countries citing papers authored by Gérard Greig

Since Specialization

Citations

This map shows the geographic impact of Gérard Greig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérard Greig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérard Greig more than expected).

Fields of papers citing papers by Gérard Greig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérard Greig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérard Greig. The network helps show where Gérard Greig may publish in the future.

Co-authorship network of co-authors of Gérard Greig

This figure shows the co-authorship network connecting the top 25 collaborators of Gérard Greig. A scholar is included among the top collaborators of Gérard Greig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérard Greig. Gérard Greig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Greig, Gérard, Nader N. Youssef, & Federico Bolognani. (2024). Pharmacokinetics and Tolerability of a Single Dose of Apraglutide, a Novel, Long‐Acting, Synthetic glucagon‐like peptide‐2 Analog With a Unique Pharmacologic Profile, in Individuals With Impaired Renal Function. The Journal of Clinical Pharmacology. 64(6). 744–754. 1 indexed citations

Greig, Gérard, et al.. (2024). Su1949 THE EFFECT OF APRAGLUTIDE ON GASTRIC EMPTYING IN HEALTHY INDIVIDUALS: A PHASE 1 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, SINGLE-CENTER TRIAL. Gastroenterology. 166(5). S–881.

Bolognani, Federico, Annelieke C. Kruithof, Matthias Macháček, et al.. (2023). Characterization of the Pharmacokinetic and Pharmacodynamic Profile of Apraglutide, a Glucagon-Like Peptide-2 Analog, in Healthy Volunteers. Journal of Pharmacology and Experimental Therapeutics. 386(2). 129–137. 3 indexed citations

Bolognani, Federico, Matthias Macháček, Annelieke C. Kruithof, et al.. (2021). Su559 POPULATION MODEL CONFIRMS PREDICTABLE PHARMACOKINETIC (PK) AND PHARMACODYNAMIC (PD) PROFILE FOR APRAGLUTIDE - DATA FROM TWO RANDOMIZED PHASE 1 STUDIES. Gastroenterology. 160(6). S–738. 1 indexed citations

Bolognani, Federico, Pim Gal, Matthijs Moerland, et al.. (2020). The pharmacokinetic and pharmacodynamic relationship between apraglutide and citrulline: a randomized, placebo-controlled, double-blind study in healthy volunteers. Clinical Nutrition ESPEN. 40. 413–414. 2 indexed citations

Holiga, Štefan, Fabio Sambataro, Cecile Paquet Luzy, et al.. (2018). Test-retest reliability of task-based and resting-state blood oxygen level dependence and cerebral blood flow measures. PLoS ONE. 13(11). e0206583–e0206583. 54 indexed citations

Goelzer, Petra, et al.. (2016). A Physiologically Based Pharmacokinetic Model for Ganciclovir and Its Prodrug Valganciclovir in Adults and Children. The AAPS Journal. 18(6). 1453–1463. 34 indexed citations

Guerini, Elena, Simone Schadt, Gérard Greig, et al.. (2016). A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [¹⁴C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [¹³C₆]-labeled basimglurant in humans. Xenobiotica. 47(2). 144–153. 15 indexed citations

Fowler, Stephen, et al.. (2016). Low Potential of Basimglurant to Be Involved in Drug-Drug Interactions: Influence of Non–Michaelis-Menten P450 Kinetics on Fraction Metabolized. Journal of Pharmacology and Experimental Therapeutics. 360(1). 164–173. 5 indexed citations

10.

Wandel, Christoph, Paul Barrow, Georg Schmitt, et al.. (2016). Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update. Clinical and Translational Medicine. 5(1). 23–23. 1 indexed citations

11.

Meyer, Olivier, Gérard Greig, & Henry H. Holzgrefe. (2013). Comparative TQT analysis with three fully-automated platforms: Comparison to core laboratory semi-automated results. Journal of Electrocardiology. 46(6). 717.e1–717.e9. 3 indexed citations

12.

Meyer, Olivier, Georg Ferber, Gérard Greig, & Henry H. Holzgrefe. (2012). Pattern recognition analysis of digital ECGs: Decreased QT measurement error and improved precision compared to semi-automated methods. Journal of Electrocardiology. 46(2). 118–125. 6 indexed citations

13.

Kurzrock, Razelle, Amita Patnaik, Joseph Aisner, et al.. (2010). A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 16(8). 2458–2465. 158 indexed citations

14.

Souppart, C., Anne Gardin, Gérard Greig, et al.. (2008). Pharmacokinetics of Licarbazepine in Healthy Volunteers: Single and Multiple Oral Doses and Effect of Food. The Journal of Clinical Pharmacology. 48(5). 563–569. 5 indexed citations

15.

Gaudreault, Jacques, Gérard Greig, Valérie Cosson, et al.. (2008). Population pharmacokinetics of bevacizumab. Journal of Clinical Oncology. 26(15_suppl). 14570–14570. 3 indexed citations

16.

Rodón, Jordi, Amita Patnaik, Mark N. Stein, et al.. (2007). A phase I study of q3W R1507, a human monoclonal antibody IGF-1R (insulin-like growth factor receptor) antagonist in patients with advanced solid tumors. Molecular Cancer Therapeutics. 6. 10 indexed citations

17.

Rodón, Jordi, Amita Patnaik, Mark N. Stein, et al.. (2007). A phase I study of q3W R1507, a human monoclonal antibody IGF-1R antagonist in patients with advanced cancer. Journal of Clinical Oncology. 25(18_suppl). 3590–3590. 40 indexed citations

18.

Serra, Denise, Melton B. Affrime, Martin P. Bedigian, et al.. (2005). QT and QTc Interval With Standard and Supratherapeutic Doses of Darifenacin, a Muscarinic M₃ Selective Receptor Antagonist for the Treatment of Overactive Bladder. The Journal of Clinical Pharmacology. 45(9). 1038–1047. 48 indexed citations

19.

Scott, Graham, Stuart Osborne, Gérard Greig, et al.. (2003). Pharmacokinetics of Pimecrolimus, a Novel Nonsteroid Anti-Inflammatory Drug, After Single and Multiple Oral Administration. Clinical Pharmacokinetics. 42(14). 1305–1314. 6 indexed citations

20.

Rappersberger, Klemens, Michael Komar, Klaus Wolff, et al.. (2002). Pimecrolimus Identifies a Common Genomic Anti-inflammatory Profile, is Clinically Highly Effective in Psoriasis and is Well Tolerated. Journal of Investigative Dermatology. 119(4). 876–887. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact